Paragon Biosciences is a global leader in life science innovation, creating and funding cutting-edge biology-based companies. Their portfolio includes Harmony Biosciences, developing new treatments for sleep-wake disorders, Emalex Biosciences focusing on central nervous system disorders, and Evozyne using generative AI for novel protein systems and disease treatments.
Additionally, Castle Creek Biosciences specializes in cell and gene therapy for skin and connective tissue diseases, while CiRC Biosciences aims to develop regenerative medicines to restore vision lost to degenerative retinal diseases. Paragon Biosciences is at the forefront of accelerating advancements in the life science industry.
Generated from the website
